Palomino Laboratories (PALX) Notes Payables (2022 - 2025)
Palomino Laboratories (PALX) posted Notes Payables of $318750.0 for Q3 2025, up 1493.75% sequentially from $20000.0 in Q2 2025, and up 144.73% YoY from $130247.0 in Q3 2024.
Palomino Laboratories (PALX) Notes Payables (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Notes Payables for 4 years, with the latest figure at $318750.0 in Q3 2025.
- Quarterly Notes Payables rose 144.73% year-over-year to $318750.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $318750.0 (up 144.73% YoY) and the FY2024 annual result came in at $3140.0, down 96.05% from the prior year.
- Notes Payables climbed to $318750.0 in Q3 2025 per PALX's latest filing, from $20000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $318750.0 in Q3 2025 and troughed at $304.0 in Q4 2022.
- A 4-year average of $103956.8 and a median of $79563.0 in 2023 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2023 and 2024: Notes Payables surged 26072.04% in 2023, then slumped 96.05% in 2024.
- Over 4 years, Notes Payables stood at $304.0 in 2022, then soared by 26072.04% to $79563.0 in 2023, then plunged by 96.05% to $3140.0 in 2024, then soared by 10051.27% to $318750.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $318750.0, $20000.0, and $275000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 318,750.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 275,000.00 |
| Dec 31, 2024 | 3,140.00 |
| Sep 30, 2024 | 130,247.00 |
| Jun 30, 2024 | 110,204.00 |
| Mar 31, 2024 | 79,563.00 |
| Dec 31, 2023 | 79,563.00 |
| Sep 30, 2023 | 22,797.00 |
| Dec 31, 2022 | 304.00 |